Vanguard Group’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.94M Sell
4,115,250
-279,994
-6% -$200K ﹤0.01% 3391
2025
Q1
$2.86M Buy
4,395,244
+186,744
+4% +$122K ﹤0.01% 3365
2024
Q4
$7.74M Buy
4,208,500
+13,428
+0.3% +$24.7K ﹤0.01% 3078
2024
Q3
$14.5M Buy
4,195,072
+639,732
+18% +$2.21M ﹤0.01% 2766
2024
Q2
$10.4M Buy
3,555,340
+532,550
+18% +$1.56M ﹤0.01% 2892
2024
Q1
$17.1M Buy
3,022,790
+132,790
+5% +$750K ﹤0.01% 2679
2023
Q4
$12.4M Buy
2,890,000
+21,238
+0.7% +$91.1K ﹤0.01% 2831
2023
Q3
$9.95M Buy
2,868,762
+38,854
+1% +$135K ﹤0.01% 2880
2023
Q2
$13.2M Buy
2,829,908
+52,946
+2% +$246K ﹤0.01% 2794
2023
Q1
$12.8M Buy
2,776,962
+132,290
+5% +$611K ﹤0.01% 2804
2022
Q4
$21.4M Buy
2,644,672
+594,396
+29% +$4.8M ﹤0.01% 2593
2022
Q3
$11.4M Buy
2,050,276
+12,951
+0.6% +$71.9K ﹤0.01% 2896
2022
Q2
$10.6M Sell
2,037,325
-193,672
-9% -$1.01M ﹤0.01% 2963
2022
Q1
$18.3M Buy
2,230,997
+113,190
+5% +$930K ﹤0.01% 2825
2021
Q4
$31.5M Buy
2,117,807
+2,776
+0.1% +$41.3K ﹤0.01% 2613
2021
Q3
$40M Buy
2,115,031
+51,836
+3% +$979K ﹤0.01% 2485
2021
Q2
$38.4M Buy
2,063,195
+23,206
+1% +$431K ﹤0.01% 2509
2021
Q1
$46.4M Buy
2,039,989
+116,370
+6% +$2.65M ﹤0.01% 2360
2020
Q4
$41.8M Buy
1,923,619
+623,814
+48% +$13.5M ﹤0.01% 2295
2020
Q3
$13.1M Buy
1,299,805
+300,840
+30% +$3.02M ﹤0.01% 2656
2020
Q2
$7.75M Buy
998,965
+620,787
+164% +$4.82M ﹤0.01% 2890
2020
Q1
$3.86M Buy
378,178
+37,591
+11% +$383K ﹤0.01% 3079
2019
Q4
$3.75M Buy
340,587
+17,288
+5% +$190K ﹤0.01% 3264
2019
Q3
$2.94M Buy
323,299
+128,045
+66% +$1.16M ﹤0.01% 3316
2019
Q2
$2.22M Buy
195,254
+18,482
+10% +$210K ﹤0.01% 3447
2019
Q1
$2.01M Buy
176,772
+52,489
+42% +$598K ﹤0.01% 3448
2018
Q4
$1.12M Buy
+124,283
New +$1.12M ﹤0.01% 3535